ARS Pharmaceuticals annual gross margin
2023
2024
2025
ARS Pharmaceuticals's gross margin was 75.77% for fiscal 2025.
View full ARS Pharmaceuticals company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 75.77% | −23.14 pp |
| 2024 | 2024-12-31 | 98.90% | −1.10 pp |
| 2023 | 2023-12-31 | 100.00% | — |
Between the periods ended 2023-12-31 and 2025-12-31, ARS Pharmaceuticals's gross margin decreased from 100.00% to 75.77%, a change of −24.23 percentage points.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ARS Pharmaceuticals source filings ↗